WEST PHARMACEUTICAL SERVICES, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- WEST PHARMACEUTICAL SERVICES, INC. payments for repurchase of common stock for the quarter ending 2026-06-30 was $156.70M, a 31240.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. payments for repurchase of common stock for the quarter ending 2026-03-31 was $297.60M, a 122.92% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. payments for repurchase of common stock for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. payments for repurchase of common stock for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. payments for repurchase of common stock for fiscal 2025 was $134.00M, a 76.11% decline from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. payments for repurchase of common stock for fiscal 2024 was $560.90M, a 27.97% increase from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. payments for repurchase of common stock for fiscal 2023 was $438.30M, a 116.12% increase from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. payments for repurchase of common stock for fiscal 2022 was $202.80M, a 47.92% increase from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $156.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $454.30M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $297.60M 10-Q · filed 2026-04-23 | $298.10M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $134.00M 10-K · filed 2026-02-17 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $188.40M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $240.80M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $133.50M 10-Q · filed 2026-04-23 | $427.40M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $54.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $560.90M 10-K · filed 2026-02-17 |
| 2024-09-30 | $52.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $683.50M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $187.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $658.90M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $267.00M 10-Q · filed 2025-04-24 | $645.20M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $177.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $438.30M 10-K · filed 2026-02-17 |
| 2023-09-30 | $27.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $261.20M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $173.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $260.60M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $60.10M 10-Q · filed 2024-04-25 | $115.80M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $202.80M 10-K · filed 2025-02-18 |
| 2022-09-30 | $27.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $202.90M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $28.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $175.70M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $147.10M 10-Q · filed 2023-04-27 | $147.10M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $137.10M 10-K · filed 2024-02-20 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $137.10M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $137.10M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $137.10M 10-Q · filed 2022-04-28 | $137.10M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $115.50M 10-K · filed 2023-02-21 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $115.50M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $115.50M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $115.50M 10-Q · filed 2021-04-30 | $115.50M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $83.10M 10-K · filed 2022-02-22 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $83.10M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $83.10M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $83.10M 10-Q · filed 2020-04-24 | $106.00M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $70.80M 10-K · filed 2021-02-23 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $118.30M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $22.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $118.30M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $47.90M 10-Q · filed 2019-05-08 | $95.40M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $47.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $74.40M 10-K · filed 2020-02-24 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $52.30M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $61.90M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $26.90M 10-Q · filed 2018-05-08 | $70.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $25.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $52.20M 10-K · filed 2019-02-28 |
| 2016-09-30 | $9.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $26.80M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $8.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $17.20M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $9.10M 10-Q · filed 2017-05-05 | $9.10M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 10-K · filed 2018-02-26 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-06 | |
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 | |
| 2012-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $4.70M 10-K · filed 2013-02-27 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $2.20M derived: sum of 4 quarters · filed 2013-02-27 |
| 2012-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $2.20M derived: sum of 4 quarters · filed 2013-02-27 |
| 2012-03-31 | $600.00K 10-Q · filed 2012-05-04 | $2.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $3.50M 10-K · filed 2013-02-27 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $3.60M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $3.50M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $2.10M 10-Q · filed 2012-05-04 | $2.20M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $2.10M 10-K · filed 2013-02-27 |
| 2010-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $2.20M derived: sum of 4 quarters · filed 2012-03-01 |
| 2010-06-30 | $100.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-08-08 | $2.50M derived: sum of 4 quarters · filed 2012-03-01 |
| 2010-03-31 | $2.00M 10-Q · filed 2011-05-05 | |
| 2009-12-31 | $200.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $1.30M 10-K/A · filed 2012-03-01 |
| 2009-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | |
| 2008-12-31 | $5.20M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |